Strategic Partnerships Eurobio Scientific has a growing track record of exclusive distribution and licensing agreements with international diagnostics players, presenting a clear opportunity to position complementary tests and automated solutions to expand their partner network and accelerate co-marketed launches.

Portfolio Expansion Recent launches and acquisitions of portfolio widening products across transplantation, infectious diseases, life sciences, and cancer create openings to cross-sell adjacent diagnostic assays, automation solutions, and proprietary reagents to existing hospital and private lab customers.

In-Vitro Diagnostics Focus As a French leader in in vitro diagnostics with internal production capabilities and a certified 400 m² clean room, there is potential to upsell end-to-end solutions—from reagent kits to automated platforms—for volume-driving labs seeking integrated supply and quality assurance.

Geographic & Market Growth Strong presence in France with expansion potential across European markets through partner channels, enabling targeted outreach to oncology, transplant, and infectious disease laboratories needing validated, locally supported diagnostic portfolios.

Key Accounts & Financing Active collaborations with notable partners (CareDx, Biovica, ABL Diagnostics, Canhelp Genomics) indicate a receptiveness to licensing and distribution deals; sales efforts can emphasize enterprisewide solutions, bundled offerings, and favorable commercial terms to win strategic accounts.